【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Venous Thromboembolism 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Venous Thromboembolism 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Venous Thromboembolism Therapeutics Clinical Trials 32
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
C. H. Boehringer Sohn AG & Co. KG 34
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 34
Bayer AG 39
Clinical Trial Overview of Bayer AG 39
GlaxoSmithKline plc 42
Clinical Trial Overview of GlaxoSmithKline plc 42
Sanofi 44
Clinical Trial Overview of Sanofi 44
Astellas Pharma Inc. 46
Clinical Trial Overview of Astellas Pharma Inc. 46
Pfizer Inc. 48
Clinical Trial Overview of Pfizer Inc. 48
Bristol-Myers Squibb Company 50
Clinical Trial Overview of Bristol-Myers Squibb Company 50
Daiichi Sankyo Company, Limited 52
Clinical Trial Overview of Daiichi Sankyo Company, Limited 52
AstraZeneca PLC 54
Clinical Trial Overview of AstraZeneca PLC 54
Johnson & Johnson 56
Clinical Trial Overview of Johnson & Johnson 56
Clinical Trial Overview of Top Institutes / Government 57
McMaster University 57
Clinical Trial Overview of McMaster University 57
Hamilton Health Sciences 58
Clinical Trial Overview of Hamilton Health Sciences 58
Ottawa Hospital Research Institute 59
Clinical Trial Overview of Ottawa Hospital Research Institute 59
The Utrecht Institute for Pharmaceutical Sciences 60
Clinical Trial Overview of The Utrecht Institute for Pharmaceutical Sciences 60
Universita degli Studi dell’Insubria 61
Clinical Trial Overview of Universita degli Studi dell’Insubria 61
Capital District Health Authority, Canada 62
Clinical Trial Overview of Capital District Health Authority, Canada 62
Centre Hospitalier Universitaire de Grenoble 63
Clinical Trial Overview of Centre Hospitalier Universitaire de Grenoble 63
Hadassah Medical Organization 64
Clinical Trial Overview of Hadassah Medical Organization 64
Juntendo University School of Medicine 65
Clinical Trial Overview of Juntendo University School of Medicine 65
Leiden University Medical Center 66
Clinical Trial Overview of Leiden University Medical Center 66
Five Key Clinical Profiles 67
Appendix 105
Abbreviations 105
Definitions 105
Research Methodology 106
Secondary Research 106
About GlobalData 107
Contact Us 107
Disclaimer 107
Source 107
【レポート販売概要】
■ タイトル：静脈血栓塞栓症(Venous Thromboembolism)：世界の治験レビュー（2015年上半期版）■ 英文：Venous Thromboembolism Global Clinical Trials Review, H1, 2015
■ 発行日：2015年4月17日
■ 調査会社：GlobalData
■ 商品コード：GDHC2625CTIDB
■ 調査対象地域：グローバル
- M2M、テレマティクスソリューション、市場機会（M2M and Telematics Solutions and Market Opportunities）The first M2M applications were targeted toward communication models and state machines however it has now grown to cover a wide variety of options including the latest technologies. Most of these technologies are aimed toward personal or home networks and even tracking and monitoring applications. If we see a list of the applications being developed in the M2M segment then the following are the m …
- キャンプ用照明およびランタンの世界市場2017-2021：懐中電灯、ランタン、ヘッドランプAbout Camping Lights and LanternsCamping lights and lanterns are essential sources of power for camping and backpacking tours. Apart from illuminating the camping space, modern camping lanterns come with extra features like Universal Serial Bus (USB) ports to charge one's smartphone or MP3 player, a red light for night vision, a yellow light that keeps insects away, remote control operation, a SOS …
- 透明導電体市場2013The past year has seen major changes in the world of transparent conductors (TCs). Efforts by Intel and especially Microsoft to bring touch to every laptop have suggested new opportunities for non-ITO TCs. Meanwhile, the continued rapid growth in tablet computing can only be regarded as a positive sign for TCs. On the other hand, new ways of producing both touch panels and displays suggest that di …
- Unit Corporation社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Unit Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Unit Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
- アレルゲン免疫療法の世界市場2019-2023112 pages, November 2018 About this market The emerging drug development technologies is likely to help the market grow during the forecast period. The recent advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more efficient immunotherapies for the treatment of various allergies. Technavio’s analysts have predicted that the allergy immunotherapies ma …
- Tasigna (Chronic Myeloid Leukemia)：市場予測と分析（～2022）Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the presence of the BCR-ABL fusion protein. The stage of CML is classified …
- ガラス包装の世界市場分析：用途別（食品・飲料、ビール、医薬品）、セグメント予測、-2020The global market for Glass Packaging is expected to reach USD 68.4 billion by 2020, according to a new study by Grand View Research, Inc. Growing beer consumption, especially in parts of Eastern Europe and Asia Pacific is expected to be a key driver for the growth of the market over the next five years. In addition, the increasing preference towards use of glass in packaging of food and beverage, …
- プロテインエンジニアリングの世界市場：プロテインエンジニアリング技術、製品（機器、サービス）、蛋白質種類、需要先、地域別分析Developing Asian countries such as the China and India are lucrative markets for protein engineering, owing to increase in R&D investment by the biologics companies in these regions. The report segments the global protein engineering market product, technology, protein type, end user, and region. Instruments accounted for the largest share of the global Protein engineering market, by product in 20 …
- イギリスの気道装置・麻酔装置市場United Kingdom Airway and Anesthesia Devices Market Outlook to 2021 Summary GlobalData’s new report, "United Kingdom Airway and Anesthesia Devices Market Outlook to 2021", provides key market data on the United Kingdom Airway and Anesthesia market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Anesthesia Cir …
- 音声クローニングの世界市場予測（～2023年）Global voice cloning market is expected to grow at a CAGR of 30.7% during the forecast periodMarketsandMarkets expects the global voice cloning market size to grow from USD 456 million in 2018 to USD 1,739 million by 2023, at a Compound Annual Growth Rate (CAGR) of 30.7% during the forecast period. Major growth drivers for the market include the rapid surge in the demand for Internet of Things (Io …
- 世界主要国における腫瘍マーカー及び特殊化学検査市場2015Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 320-page report from VPGMarketResearch.com contains 83 tables and provides analysis of the global tumor markers and special chemistry testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.&n …
- ソリッドコントロール装置の世界市場：シェール・シェーカー及びスクリーン、マッド遠心分離機、ハイドロサイクロン、マッドクリーナーThis report estimates the solids control equipment market, in terms of revenue. The market has been segmented into equipment types (Shale shakers & screen, Mud Centrifuges, Hydrocyclones, Mud cleaner, and others), applications (onshore & offshore), and regions (North America, Europe, Asia-Pacific, the Middle East & Africa, and South America). Solids control equipment plays a vital role in the dril …
- ワイヤーラインサービスの世界市場This report forecasts the wireline services market in terms of value in USD Million ($ Million). This has been segment into component regions, which has been further split into countries. The oil and gas industry witnessed high growth in the oilfield services since the financial crisis in 2009 as the oil and gas production increased and the oil prices remained well over $100/barrel. This changed i …
- 世界のモバイルヘルスケア（mHealth）市場With more than 7 Billion mobile network subscriptions worldwide, the mobile communications sector is rapidly gaining traction from a diverse range of vertical sectors. Healthcare is no exception to this trend. As healthcare providers seek to maximize their patient outreach while minimizing costs, many view mobile healthcare (or mHealth) as the solution to improve healthcare cost-efficiency. mHealt …
- 止血剤・組織密閉剤の世界市場：製品別（局所止血剤、接着剤・組織シーラント）、地域別、セグメント予測The global hemostasis and tissue sealing agents market size is expected to reach USD 10.34 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 8.7% during the forecast period. The agents have gained popularity over time due to their ability to prevent blood loss. Rapid growth of minimal invasive technology and demand for faster recovery by …
